Breaking News and Updates
- Abolition Of Work
- Alternative Medicine
- Artificial Intelligence
- Atlas Shrugged
- Ayn Rand
- Basic Income Guarantee
- Big Tech
- Black Lives Matter
- Boca Chica Texas
- Casino Affiliate
- Cbd Oil
- Chess Engines
- Cloud Computing
- Conscious Evolution
- Corona Virus
- Cosmic Heaven
- Designer Babies
- Donald Trump
- Elon Musk
- Ethical Egoism
- Fifth Amendment
- Fifth Amendment
- Financial Independence
- First Amendment
- Fiscal Freedom
- Food Supplements
- Fourth Amendment
- Fourth Amendment
- Free Speech
- Freedom of Speech
- Gene Medicine
- Genetic Engineering
- Germ Warfare
- Golden Rule
- Government Oppression
- High Seas
- Hubble Telescope
- Human Genetic Engineering
- Human Genetics
- Human Longevity
- Immortality Medicine
- Intentional Communities
- Jordan Peterson
- Life Extension
- Marie Byrd Land
- Mars Colonization
- Mars Colony
- Mind Uploading
- Minerva Reefs
- Modern Satanism
- Moon Colonization
- National Vanguard
- New Utopia
- Online Casino
- Personal Empowerment
- Political Correctness
- Politically Incorrect
- Post Human
- Post Humanism
- Private Islands
- Quantum Computing
- Quantum Physics
- Resource Based Economy
- Ron Paul
- Second Amendment
- Second Amendment
- Socio-economic Collapse
- Space Exploration
- Space Station
- Space Travel
- Teilhard De Charden
- The Singularity
- Tor Browser
- Transhuman News
- Victimless Crimes
- Virtual Reality
- Wage Slavery
- War On Drugs
- Zeitgeist Movement
The Evolutionary Perspective
Daily Archives: May 12, 2020
Posted: May 12, 2020 at 10:54 am
Provided by The Guardian Photograph: David Cheskin/PA
Scientists have found evidence for mutations in some strains of the coronavirus that suggest the pathogen may be adapting to humans after spilling over from bats.
The analysis of more than 5,300 coronavirus genomes from 62 countries shows that while the virus is fairly stable, some have gained mutations, including two genetic changes that alter the critical spike protein the virus uses to infect human cells.
Researchers at the London School of Hygiene and Tropical Medicine stress that it is unclear how the mutations affects the virus, but since the changes arose independently in different countries they may help the virus spread more easily.
The spike mutations are rare at the moment but Martin Hibberd, professor of emerging infectious diseases and a senior author on the study, said their emergence highlights the need for global surveillance of the virus so that more worrying changes are picked up fast.
Related: When will a coronavirus vaccine be ready?
This is exactly what we need to look out for, Hibberd said. People are making vaccines and other therapies against this spike protein because it seems a very good target. We need to keep an eye on it and make sure that any mutations dont invalidate any of these approaches.
Studies of the virus revealed early on that the shape of its spike protein allowed it to bind to human cells more efficiently than Sars, a related virus that sparked an outbreak in 2002. The difference may have helped the latest coronavirus infect more people and spread rapidly around the world.
Scientists will be concerned if more extensive mutations in the spike protein arise, not only because they may alter how the virus behaves. The spike protein is the main target of leading vaccines around the world, and if it changes too much those vaccines may no longer work. Other potential therapies, such as synthetic antibodies that home in on the spike protein, could be less effective, too.
This is an early warning, Hibberd said. Even if these mutations are not important for vaccines, other mutations might be and we need to maintain our surveillance so we are not caught out by deploying a vaccine that only works against some strains.
The scientists analysed 5,349 coronavirus genomes that have been uploaded to two major genetics databases since the outbreak began. By studying the genetic makeup of the viruses, the scientists worked out how it has diversified into different strains and looked for signs that it was adapting to its human host.
In an unpublished study that has yet to be peer reviewed, the researchers identified two broad groups of coronavirus that have now spread globally. Of the two spike mutations, one was found in 788 viruses around the world, with the other present in only 32.
The study shows that, until January, one group of coronaviruses in China escaped detection because they had a mutation in the genetic region that early tests relied on. More recent tests detect all of the known types of the virus.
Last month, an international team of scientists used genetic analyses to show that the coronavirus likely originated in bats and was not made in a lab as some conspiracy theorists have claimed.
Seattle Genetics Announces the Approval of TUKYSA (tucatinib) in Switzerland for the Treatment of Patients with Metastatic HER2-Positive Breast Cancer…
Posted: at 10:53 am
BOTHELL, Wash.--(BUSINESS WIRE)-- Seattle Genetics, Inc., Inc. (Nasdaq:SGEN) today announced that the Swiss Agency for Therapeutic Products (Swissmedic) has granted approval for TUKYSA (tucatinib) tablets in combination with trastuzumab and capecitabine, for the treatment of patients with metastatic HER2-positive breast cancer, who have previously received two or more anti-HER2 regimens in any setting, including trastuzumab, pertuzumab and trastuzumab-emtansine (TDM1).
The application for TUKYSA approval was reviewed by Swissmedic as part of Project Orbis, an initiative of the U.S. Food and Drug Administration (FDA) Oncology Center of Excellence that provides a framework for concurrent submission and review of oncology drugs among participating international regulatory agencies in Canada, Australia and Singapore. On April 17, the FDA approved TUKYSA in the U.S. under the FDAs Real-Time Oncology Review (RTOR) pilot program, four months prior to its action date, and represented the first new drug approved under Project Orbis.
Were grateful to Swissmedic for their collaboration through FDAs Project Orbis in approving this important new medicine in Switzerland, said Jennifer Stephens, Vice President of Regulatory Affairs at Seattle Genetics. We're committed to bringing new targeted therapies to patients, and we are excited about this important first step toward making TUKYSA available to patients in Switzerland.
TUKYSA is an oral, small molecule tyrosine kinase inhibitor (TKI) of HER2, a protein that contributes to cancer cell growth.i,ii
The approval is based on results from the pivotal trial HER2CLIMB, a randomized (2:1), double-blind, placebo-controlled trial that enrolled 612 patients with HER2-positive unresectable locally advanced or metastatic breast cancer who had previously received, either separately or in combination, trastuzumab, pertuzumab, and ado-trastuzumab emtansine (T-DM1). The study results were published in The New England Journal of Medicine in December 2019.
About HER2-Positive Breast Cancer
Patients with HER2-positive breast cancer have tumors with high levels of a protein called human epidermal growth factor receptor 2 (HER2), which promotes the growth of cancer cells. In 2018, more than two million new cases of breast cancer were diagnosed worldwide, including 522,513 in Europe. iii Between 15 and 20 percent of breast cancer cases are HER2-positive.iv Historically, HER2-positive breast cancer tends to be more aggressive and more likely to recur than HER2-negative breast cancer.v,vi,vii Up to 50 percent of metastatic HER2-positive breast cancer patients develop brain metastases over time.viii,ix,x
About TUKYSA (tucatinib)
TUKYSA is an oral medicine that is a tyrosine kinase inhibitor of the HER2 protein. In vitro (in lab studies), TUKYSA inhibited phosphorylation of HER2 and HER3, resulting in inhibition of downstream MAPK and AKT signaling and cell growth (proliferation), and showed anti-tumor activity in HER2-expressing tumor cells. In vivo (in living organisms), TUKYSA inhibited the growth of HER2-expressing tumors. The combination of TUKYSA and the anti-HER2 antibody trastuzumab showed increased anti-tumor activity in vitro and in vivo compared to either medicine alone.xi In the U.S., TUKYSA is approved in combination with trastuzumab and capecitabine for adult patients with advanced unresectable or metastatic HER2-positive breast cancer, including patients with brain metastases, who have received one or more prior anti-HER2-based regimens in the metastatic setting.
Important U.S. Safety Information
Warnings and Precautions
If diarrhea occurs, administer antidiarrheal treatment as clinically indicated. Perform diagnostic tests as clinically indicated to exclude other causes of diarrhea. Based on the severity of the diarrhea, interrupt dose, then dose reduce or permanently discontinue TUKYSA.
Monitor ALT, AST, and bilirubin prior to starting TUKYSA, every 3 weeks during treatment, and as clinically indicated. Based on the severity of hepatoxicity, interrupt dose, then dose reduce or permanently discontinue TUKYSA.
Serious adverse reactions occurred in 26% of patients who received TUKYSA. Serious adverse reactions in 2% of patients who received TUKYSA were diarrhea (4%), vomiting (2.5%), nausea (2%), abdominal pain (2%), and seizure (2%). Fatal adverse reactions occurred in 2% of patients who received TUKYSA including sudden death, sepsis, dehydration, and cardiogenic shock.
Adverse reactions led to treatment discontinuation in 6% of patients who received TUKYSA; those occurring in 1% of patients were hepatotoxicity (1.5%) and diarrhea (1%). Adverse reactions led to dose reduction in 21% of patients who received TUKYSA; those occurring in 2% of patients were hepatotoxicity (8%) and diarrhea (6%).
The most common adverse reactions in patients who received TUKYSA (20%) were diarrhea, palmar-plantar erythrodysesthesia, nausea, fatigue, hepatotoxicity, vomiting, stomatitis, decreased appetite, abdominal pain, headache, anemia, and rash.
In HER2CLIMB, Grade 3 laboratory abnormalities reported in 5% of patients who received TUKYSA were: decreased phosphate, increased ALT, decreased potassium, and increased AST. The mean increase in serum creatinine was 32% within the first 21 days of treatment with TUKYSA. The serum creatinine increases persisted throughout treatment and were reversible upon treatment completion. Consider alternative markers of renal function if persistent elevations in serum creatinine are observed.
Use in Specific Populations
For more information, please see the full Prescribing Information for TUKYSA here.
About Seattle Genetics
Seattle Genetics, Inc. is a global biotechnology company that discovers, develops and commercializes transformative cancer medicines to make a meaningful difference in peoples lives. ADCETRIS (brentuximab vedotin) and PADCEVTM (enfortumab vedotin-ejfv) use the companys industry-leading antibody-drug conjugate (ADC) technology. ADCETRIS is approved in certain CD30-expressing lymphomas, and PADCEV is approved in certain metastatic urothelial cancers. TUKYSATM (tucatinib), a small molecule tyrosine kinase inhibitor, is approved in certain HER2-positive metastatic breast cancers. The company is headquartered in Bothell, Washington, with locations in California, Switzerland and the European Union. For more information on our robust pipeline, visit http://www.seattlegenetics.com and follow @SeattleGenetics on Twitter.
Forward Looking Statements
Certain statements made in this press release are forward looking, such as those, among others, relating to the therapeutic potential of TUKYSA including its efficacy, safety and therapeutic uses including the potential use of TUKYSA in combination with trastuzumab and capecitabine for the treatment of patients with metastatic HER2-positive breast cancer, who have previously received two or more anti-HER2 regimens in any setting, including trastuzumab, pertuzumab and trastuzumab-emtansine (TDM1) and the potential to bring TUKYSA to patients in Switzerland. Actual results or developments may differ materially from those projected or implied in these forward-looking statements. Factors that may cause such a difference include reimbursement processes, the extent of reimbursement, the possibility that adverse events or safety signals may occur, the possibility that the ultimate utilization and adoption of TUKYSA by prescribing physicians may be limited, including due to impacts related to the COVID-19 pandemic, the possibility of difficulties in supplying and commercializing a new therapeutic agent, and the possibility of adverse regulatory actions. More information about the risks and uncertainties faced by Seattle Genetics is contained under the caption Risk Factors included in the companys Quarterly Report on Form 10-Q for the quarter ended March 31, 2020 filed with the Securities and Exchange Commission. Seattle Genetics disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
i TUKYSA [package insert]. Bothell, WA: Seattle Genetics, Inc.ii Anita Kulukian, Patrice Lee, Janelle Taylor, et al. Preclinical Activity of HER2-Selective Tyrosine Kinase Inhibitor Tucatinib as a Single Agent or in Combination with Trastuzumab or Docetaxel in Solid Tumor ModelsMol Cancer Ther 2020;19:976-987.iii Breast. Globocan 2018. World Health Organization. 2019. https://gco.iarc.fr/today/data/factsheets/cancers/20-Breast-fact-sheet.pdf iv Slamon D, Clark G, Wong S, et al. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science. 1987; 235(4785): 177-82.v Loibli S, Gianni L. HER2-positive breast cancer. Lancet. 2017; 389(10087): 2415-29.vi Slamon D, Clark G, Wong S, et al. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science. 1987; 235(4785): 177-82.vii Breast Cancer HER2 Status. American Cancer Society website. http://www.cancer.org/cancer/breast-cancer/understanding-a-breast-cancer-diagnosis/breast-cancer-her2-status.html. Accessed March 9, 2020.viii Freedman RA, Gelman RS, Anders CK, et al. TBCRC 022: a phase II trial of neratinib and capecitabine for patients with human epidermal growth factor receptor 2-positive breast cancer and brain metastases. J Clin Oncol. 2019;37:1081-1089.ix Olson EM, Najita JS, Sohl J, et al. Clinical outcomes and treatment practice patterns of patients with HER2-positive metastatic breast cancer in the post-trastuzumab era. Breast. 2013;22:525-531.x Bendell JC, Domchek SM, Burstein HJ, et al. Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma. Cancer. 2003;97:2972-2977.xi TUKYSA [package insert]. Bothell, WA: Seattle Genetics, Inc.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200512005217/en/
Posted: at 10:51 am
Societies need to move beyond reacting to the consequences of violence to changing norms of behavior that allow violence to occur.
One of the innumerable awful side effects of the COVID-19 pandemic has been a rise around the world in reported cases of domestic violence. Across the Oceania region there have been reports that violence against women and children has spiked, from Australia and New Zealand to Fiji and Samoa. While governments have a long list of competing interests they will have to prioritize due to the pandemic, it is of critical importance that domestic violence is not ignored. It is an issue of basic human security, with immeasurable negative consequences.
It has long been acknowledged that women are most likely to be victims of violence from within their own home, either by a partner or another family member. It is also incredibly difficult to measure the true scale of violence against women, as most incidences of both domestic violence and sexual assault remain unreported either due to a fear of repercussions or a distrust of justice systems.
Yet even with just the reported cases of violence against women the statistics are brutal. The Australian governments Institute of Health and Welfare states that in Australia one woman is killed every nine days by a partner, and that one in six women have experienced physical or sexual violence from a current or former cohabiting partner. Globally the rate of violence rises to 35 percent of women, according to the United Nations.
Reasonable people read these statistics and nod along, recognizing their blunt reality, but it is important to take a step back and ask ourselves a fundamental question: If relationships and families are meant to be bonds of mutual love and care, then how does this violence exist within them?
The fact of violence is so normalized that I dont think we quite comprehend just how extraordinary it actually is that the core purpose of a relationship has been inverted in an astonishing number of cases. It is not something we should be comfortable with.
Part of this normalization stems from our societal approach to this issue. In early April, the Australian government announced that it was providing an additional $20.8 million to the states and territories to immediately reinforce frontline services that seek to assist victims of domestic violence. This was a welcome acknowledgment that the pandemic is creating an increase in instances of domestic violence, yet it remains a reactive measure: The provision of services after the fact.
At the core of this kind of response is a collective, whole of society, expectation that men will continue to commit violence against women, and the best we can do is to try to clean up afterward. We remain at a complete loss about how to reform masculinity away from this instinctive use of violence as an instrument of human interaction. Yet if we continue to expect this kind of behavior from men we will maintain its insidious and destructive presence in our societies. Social values that tolerate these abuses and justice systems that downplay them perpetuate the violence.
There are obviously limited actions that governments can take toward getting in front of this issue, but it remains a matter that they should take incredibly seriously. If providing basic human security is the primary function of states, then millions of female citizens are currently existing in insecure conditions, demonstrating a failure of the states duty. These millions of individual cases of insecurity also have the ability to compound into wider security dilemmas, as is the case with the related issue of cross-border human trafficking. In this way, states should consider the continued prevalence of domestic violence as an internal security threat.
The financial burden that countries carry from these abuses should also be a considerable concern for governments. It is estimated that domestic violence costs Australia $14 billion a year, alongside the far greater costs in the destruction of peoples lives. In regards to the new environment created by the COVID-19 pandemic it should also be acknowledged that many women may now have their personal financial resources diminished, affecting their ability to leave abusive relationships. Governments can provide resources to assist these women as Canberra did in early April but often the realities of peoples lives make accessing such resources difficult.
It is important that we recognize that the current insecurities created by the COVID-19 pandemic are not just related to personal health and finances. For many women, their personal safety has also been negatively affected. Women already live with violence either directly or the threat of it as an everyday facet of their existence; it should be unacceptable that this current global crisis has accentuated that reality.
If COVID-19 is prompting us to question our assumptions about how states should be organized, then the increase in domestic violence due to the virus should also prompt us to question persistent harmful norms of human behavior. Collectively, we need to question whether we will continue to accept violence against women as an issue that we can only respond to after the fact, or whether we have the will to wholeheartedly reject such violence, and seek to find ways to evolve masculinity away from these destructive traits.
If you are in need of help in Australia a list of resources is available here; resources for those in New Zealand are available here.
Go here to see the original:
PLAE and BeaverFit formalise partnership to boost athletic training options in Oceania – Australasian Leisure Management
Posted: at 10:51 am
Leading sports flooring provider PLAE and functional training equipment suppliers BeaverFit have agreed a new joint-venture to expand athletic training solutions in the Oceanic region.
PLAEs new formal partnership with UK-founded BeaverFit presents an expanded range of athletic training solutions and follows the two companies having collaborated on a number of projects globally in recent years.
The partnership, which is set to increase their scope within the industry, will see PLAEs Australian-based office, in collaboration with BeaverFit, manufacture the Beaverfit range in Australia, adding its diversity of outdoor training solutions to its already extensive consultative offering.
Founded in 2010 by Tom Beaver, BeaverFit is the original designer and manufacturer of patented shipping-container training lockers. BeaverFit training solutions have been used by military units worldwide in need of a flexible and semi-permanent training solution for large groups.
With PLAEs extensive background and experience with professional sporting clubs, schools, universities and council projects, being able to able to partner with BeaverFit to offer end-to-end outdoor training solutions for Australian clients is seen as a solution that will solve industry limitations.
PLAEs continued innovation and growth throughout Oceania has seen major projects completed in recent times at the Canberra Raiders Centre of Excellence, St Kilda Football Club, Shore School Physical Education Centre, YMCA Hawthorn Aquatic and Leisure Centre and many more private and commercial facilities.
In a statement, the company advised the new joint venture with BeaverFit will see PLAE take new steps into the outdoor training space, combining its experience in surfacing and customised solutions with BeaverFits Training Lockers. PLAE will project manage and maintain all elements of the process throughout the Oceania region, from civil and structural reviews through to equipment design, engineering, accessories, concrete base preparation and construction.
In consultation with PLAE's in-house Design and Construct team, a previously under-utilised area within a school campus, a council carpark, a sporting clubs training base or a commercial gym facility can now be converted into a dynamic training experience for athletes of all kinds.
A true partnership in every sense, PLAE and BeaverFit look forward to enhancing the training experience throughout the region in the coming years.
Click hereto contact PLAE via theirAustralasian Leisure ManagementSupplier Directory entry.
25th September 2019 - Australian researchers find that higher intensity workouts improve health and reduce mortality
16th August 2019 - Global sports flooring company PLAE launches Brand Ambassador Program into Australia
25th July 2019 - Canberras Project Fitness Group to transition to HIIT Republic brand as it joins Viva Leisure stable
8th July 2019 - Step into Life launches stand-alone HiiT sessions
17th January 2019 - Research shows HIIT training as more than another fitness fad
10th April 2018 - Increasing use of synthetic turf in indoor training areas
15th February 2018 - PLAE looks to grow international business with innovative performance solutions
1st July 2017 - Les Mills-backed researcher highlights benefits of high intensity interval training
9th August 2016 - Sydney Uni Sport and Fitness installation marks arrival of PLAE sport floor options
Asking a small favourWe hope that you value the news that we publish so while you're here can we ask for your support?
The news we publish atwww.ausleisure.com.auis independent, credible (we hope) and free for you to access, with no pay walls and no annoying pop-up ads.
However, as an independent publisher, can we ask for you to support us by subscribing to the printedAustralasian Leisure Managementmagazine - if you don't already do so.
Published bi-monthly since 1997, the printedAustralasian Leisure Managementdiffers from this website in that it publishes longer, in-depth and analytical features covering aquatics, attractions, entertainment, events, fitness, parks, recreation, sport, tourism and venues management.
Subscriptions cost just $90 a year.
Click hereto subscribe.
See the original post here:
Oceania Healthcare Invites Kiwis To Take A Walk In Nurses’ Shoes This International Nurses Day – Scoop.co.nz
Posted: at 10:51 am
Tuesday, 12 May 2020, 9:34 amPress Release: Oceania Healthcare
Leading aged care provider, Oceania Healthcare will bemarking International Nurses Day with the launch of a uniqueinitiative In Their Shoes a celebration ofthe dedicated and clinically skilled nurses who work at theforefront of New Zealands aged care sector.
OceaniaHealthcare will gift each of their several hundred frontlinenurses around the country a pair of custom Allbirds - whilethe story of a day in those shoes will be brought to lifefor Kiwis across print, digital, radio and PR.
OceaniaHealthcares GM Nursing & Clinical Strategy, DrFrances Hughes, said they wanted to do something special tomark International Nurses Day this year, particularlyagainst the backdrop of the dedication shown by ourhealthcare sector throughout COVID-19.
The theme ofthis years celebration is nursing the world tohealth, and with In Their Shoes, wereacknowledging every facet of what is required to deliver onthat vital role. The initiative is a recognition not just ofthe kindness and compassion that nurses bring to each andevery interaction but, more importantly, their skills,knowledge, commitment and professionalism.
Nursesare adept and highly-skilled problem solvers, criticalthinkers, clinical decision-makers, planners, organisers,and patient advocates who are continually training andupskilling to be able to provide us with the very best levelof care.
Within the aged care sector, inparticular, COVID-19 has been a vivid reminder of theimportance of that continued investment in our nurses,because it does directly translate to the health andwellbeing of our aged population. Thats why we wanted toshow our respect for their continued, unparalleled hardwork.
Oceania Healthcare Chief Executive EarlGasparich adds, For so many, their view of the nursingprofession is defined by that softer side of the story so we wanted to take International Nurses Day as anopportunity to acknowledge our nurses for the incredibleskills and expertise they bring to our business and ourcommunities.
This gift is just a small token ofrespect for the skill and dedication this communitydemonstrates day in and day out, making a huge difference tothe lives of some of our most vulnerable, and treasuredcommunities.
To mark the day, each of our nurseswill be gifted a pair of bespoke Allbirds, with a speciallycrafted message in the insoles of what it's like to walk aday in their shoes a token of our respect for the workthat they do.
If these shoes couldtalk,
They would tell a story thats notoften shared.
A tale of dedication, knowledgeand putting in the mahi,
To care for those whoonce cared for you and me.
An account of mileswalked and corridors paced.
If these shoescould talk,
It would be of education,experience and intuition,
Applied in equalmeasure.
Tales of patient advocacy and clinicalexpertise,
To bring comfort and kindness toevery day.
If these shoes couldtalk,
They would tell the story of an aged carenurse.
Thank you for the extra miles you go tocare for those in need.
We celebrate you todayand every day.
Allbirds said "We've been inspiredby the way New Zealanders have banded together in the faceof monumental challenges, led by these incredible frontlineworkers. It's great to see organisations like Oceaniashowing a little extra appreciation for nurses this year, asthese healthcare professionals have been so instrumental inkeeping their communities safe andhealthy.
International Nurses Day (IND) iscelebrated around the world every 12 May, the anniversary ofFlorence Nightingales birth. Florence Nightingale was thefounder of modern nursing, and a British social reformer andstatistician.
To find out more about the initiative,head to InTheirShoes.co.nz
Become a member Find out more
Posted: at 10:51 am
Published on May 11, 2020
New Zealand standout Mose Auimatagi Jr. is raring to get back in the ring after it was announced he had linked up with Dragon Fire Boxing headed up by Oceania boxing kingpin Tony Tolj.
Auimatagi Jr. has had a baptism by fire since he turned professional, having already successfully competed for the WBA Oceania and OBPF Super Middleweight titles against now stablemate Kerry Foley. The heavy-hitting Kiwi has also held the New Zealand middleweight title on two occasions and holds a knockout win against world rated Reagan Dessaix who is also under the Dragon Fire Boxing banner.
Auimatagi Jr. opened up about his career success so far and his link-up with manager Tolj.
Auimatagi said, Im absolutely delighted to have linked up with Tony Tolj and Dragon Fire Boxing. Dragon Fire Boxing and Tony have established themselves as the most powerful company in the Oceania region, but its the honesty and professionalism that Tony has that really attracted me to them and Im very excited about the future.
I have not really had any easy fights as a pro. Ive boxed an undefeated Welsh fighter away from home and won via knockout on the undercard of Anthony Joshua vs Joseph Parker. I really enjoyed that experience and it showed me I have a big future in this sport. I hold wins over Kerry Foley and Reagan Dessaix who are both quality fighters so that should really show boxing fans who havent heard of me what level I am on.
With the boxing world changing, Auimatagi Jr. along with his new management Dragon Fire Boxing, has established a plan of action moving forward for the Kiwi puncher. The 25-year-old stated his plans for the immediate future, I want to clear up in the Oceania region and show that I am the best at super middleweight within Australia, New Zealand, and the surrounding areas. I really want to continue to develop by having real fights and Im sure Tony will get me these opportunities.
Id like to fight the likes of Istvan Szili who beat Jayde Mitchell and Id love a clash with Zach Dunn at some point. These are good level fighters but I believe I am more and ready to these types of talents and I believe that I am the best Oceania based fighter at 168 and 175.
See the article here:
Posted: at 10:49 am
A new report from Protocol today details that Apple has gone on a cloud computing hiring spree over the last few months. Apple has reportedly hired a handful fo software engineers from companies AWS, Docker, and others.
The report highlights four new hires:
The report explains that its notable to see Apple investing in the software side of its business. These hires also come as concerns mount over the state of Apples Information Systems & Technology group, which was described as a a Game of Thrones nightmare in a recent report.
Meanwhile, Apple announced in 2018 that it is investing $10 billion in US data centers over the next five years and this hiring seems key to that process. The report concludes:
Apple has long sought to own and control the key technologies that have made its products so successful, going so far as to hire its own mobile chip development team shortly after launching the iPhone. As the smartphone and personal computer markets mature, Apple has turned to services for much of its revenue growth over the past few years. Now it appears to be getting serious about running more of the behind-the-scenes technology that powers those services.
The full report from Protocol is well worth a read and can be found here.
FTC: We use income earning auto affiliate links. More.
Check out 9to5Mac on YouTube for more Apple news:
View original post here:
Insights on the Worldwide Healthcare Cloud Computing Industry (2019 to 2025) – Impact of COVID-19 – ResearchAndMarkets.com – Business Wire
Posted: at 10:49 am
DUBLIN--(BUSINESS WIRE)--The "Global Healthcare Cloud Computing Market By Component (Software v/s Services), By Delivery Model (Software-As-A-Service (SaaS), Others), By Deployment Mode, By Pricing Model, By Application, By End User, By Region, Forecast & Opportunities, 2025" report has been added to ResearchAndMarkets.com's offering.
The Global Healthcare Cloud Computing Market is expected to grow at a formidable rate during the forecast period. The Global Healthcare Cloud Computing Market is driven by the improving healthcare IT infrastructure. Additionally, increasing adoption of IoT, AI, big data, machine learning, among others in the healthcare industry is further expected to foster the market growth over next few years. Furthermore, increasing investments and new product launches by the key vendors operating in the market is expected to create lucrative opportunities for the market growth over next few years.
The Global Healthcare Cloud Computing Market is segmented based on component, delivery model, deployment mode, pricing model, application, end-user, company and region. Based on component, the market can be bifurcated into software and services. The software segment is expected to dominate the market during forecast period since they can manage raw patient data. The raw data collected on cloud is sorted and integrated which further helps healthcare providers in decision making process.
Regionally, the Global Healthcare Cloud Computing Market has been segmented into Asia-Pacific, North America, South America, Europe, and Middle East & Africa. Among these regions, Europe is expected to witness significant growth in the overall healthcare cloud computing market owing to the increasing geriatric population, which is susceptible to various chronic diseases such as diabetes, cancer, cardiovascular diseases, among others. This has drastically increased the number of patients getting admitted in hospitals thereby increasing the demand for healthcare cloud computing solutions in the region. This in turn is positively impacting the market growth in Europe.
Objective of the Study:
Key Topics Covered:
1. Product Overview
2. Research Methodology
3. Impact of COVID-19 on Global Healthcare Cloud Computing Market
4. Executive Summary
5. Voice of Customer
6. Global Healthcare Cloud Computing Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Component (Software v/s Services)
6.2.2. By Delivery Model (Software-As-A-Service (SaaS), Infrastructure-As-A-Service (IaaS), Platform-As-A-Service (PaaS))
6.2.3. By Deployment Mode (On-Premise v/s Cloud)
6.2.4. By Pricing Model (Pay-As-You-Go v/s Spot Pricing Model)
6.2.5. By Application (Clinical Information System v/s Non-Clinical Information System)
6.2.6. By End User (Hospitals & Clinics, Pharmacies, Ambulatory Centers, Diagnostic Centers, Others)
6.2.7. By Company (2019)
6.2.8. By Region
6.3. Product Market Map
7. Asia-Pacific Healthcare Cloud Computing Market Outlook
8. Europe Healthcare Cloud Computing Market Outlook
9. North America Healthcare Cloud Computing Market Outlook
10. South America Healthcare Cloud Computing Market Outlook
11. Middle East and Africa Healthcare Cloud Computing Market Outlook
12. Market Dynamics
13. Market Trends & Developments
14. Competitive Landscape
15. Strategic Recommendations
16. About Us & Disclaimer
For more information about this report visit https://www.researchandmarkets.com/r/ggtd0a
See more here:
Posted: at 10:49 am
The new research report entitled,GlobalCloud ComputingMarketshowcases a comprehensive study of the overall industry along with various elements such as future trends, drivers, market growth, opportunities, prospects and limitations inside the respective industry. The report provides a detailed investigation of key industry drivers and restraints. The report fulfills the desired needs of clients by offering them well-established and precisely formulated research data of the globalCloud Computingmarket. The research acknowledges major industry vendors, key regions, demand & supply, applications, technology, revenue cost, and challenges. The report explains various trends that are expected to shape the future of the market.
NOTE: Our report highlights the major issues and hazards that companies might come across due to the unprecedented outbreak of COVID-19.
DOWNLOAD FREE SAMPLE REPORT:https://www.fiormarkets.com/report-detail/386047/request-sample
The report studies the historical data and current condition of industry status and explains it through the market figures, pie charts, diagrams, etc. the document has covered all important regions and countries involved in the globalCloud Computingmarket. The report presents the regional evaluation to describe unexplored geological markets, create particular strategies for targeted regions and compare the growth of all regional industries. The prominent performance of each player actively functioning in the global market has been assessed. Details about market share, consumption analysis, and growth rate of each player are given. The authors of the report have segmented the global market as per product, application, and region.
Moreover, the report reveals in-depth details of market dynamics, pricing structures, trends, restraints, limitations, demand-supply variations, growth-boosting factors, and market variations. Profitable business plans, including acquiring, mergers, ventures, amalgamations, as well as product launches, and brand promotions are also highlighted in the report. It also provides proficient systematic analytical studies including Porters Five Forces, SWOT analysis, and Probability analysis to review the globalCloud Computingmarket thoroughly. Additionally, economic factors, differentiable opportunities, revenue shares, technological advancement are widely coated in this study.
Primitive vendors included in the market are:Amazon Web Services, Microsoft Corporation, Alibaba, SAP, IBM, Oracle, VMware, Rackspace, Salesforce, Adobe, Verizon, CenturyLink, Fujitsu, NTT Communication, Cisco Systems, Google Inc., IBM Corporation, VMware, Inc., Akamai Technologies, Hewlett Packet, and Dell Inc., and others.
Key regions discovered in this report are:North America, Europe, Asia Pacific, South America, and the Middle East and Africa.
BROWSE COMPLETE REPORT AND TABLE OF CONTENTS:https://www.fiormarkets.com/report/cloud-computing-market-by-service-iaas-paas-saas-386047.html
Comprehensive Analysis of Market Segment Type, Application:
The report explores various segments of the globalCloud Computingmarket such as types, applications, regions. The report comprises a comprehensive analysis of each market acknowledging market acceptance, attractiveness, demand, production, and predicted sales revenue by type and by the application. The study gives a comprehensive assessment of the market that includes market size in value and volume by region, manufacturers, kind and application. In short, the report offers a clear overview of the segments and sub-segments of the industry.
Furthermore, the report gives production and sales forecasts for theCloud Computingmarket, production and consumption forecasts for regional markets, production, sales and price forecasts for the market by type and consumption forecasts for the market per application. It delivers clear perspective on the most affecting driving and restraining forces in the market. The report break the sales data at the country level, with sales, revenue, and market share for key countries in the world to 2020. The anticipated growth rate expected to be recorded by each region over the estimated years has been given within the research report.
Go here to read the rest:
Global Cloud Computing Platform as a Service (PaaS) Market 2020 Insights, Key Player’s Competition, Trends, Sales, Revenue, Supply, Demand, Growth…
Posted: at 10:49 am
A research report on the Global Cloud Computing Platform as a Service (PaaS) Market offers detailed and insightful data about the several major players operating in the market. This report also contains significant analysis of the financial information, technological advancements, supply chain trends, future strategies, key developments, market footprint, as well as merger & acquisition. In addition, the Global Cloud Computing Platform as a Service (PaaS) Market can be separated into deployment type, component, end-use, and geographical region. Likewise, the Global Cloud Computing Platform as a Service (PaaS) Market report offers market segmentation by regions such as North America, Europe, Asia Pacific, and MEA. It offers an in-depth study of the crucial factors influencing the market which may include driver, opportunities, industry-specific challenges, and trends. Moreover, the Global Info Research analysis majorly focuses on developing industry trends and contains actionable insights to aid businesses identify key opportunities and create efficient growth strategies to gain their market positions.
Request a sample of this report @ https://www.orbisresearch.com/contacts/request-sample/4629251
It also analyzes the Global Cloud Computing Platform as a Service (PaaS) Market status and outlook at the regional and global level, from angle of players, product types, and other factors. Additionally, this report studies the leading competitors in the market and separates the Global Cloud Computing Platform as a Service (PaaS) Market into different segments and sub-segments. In addition, the Global Info Research report includes a brief analysis of service providers profile that comprises business units, financial status, SWOT analysis, key business priorities, and views. This study focuses on the competitive scenario which contains merger & acquisition, collaborations, joint ventures, and top players analysis. Likewise, the Global Cloud Computing Platform as a Service (PaaS) Market report also sheds light on global major top industry suppliers of industry offering statistics such as company profiles, product specification and picture, capacity, production, contact information, as well as income details. In addition to this, this research study also provides development trends and numerous marketing channels.
Key vendors/manufacturers in the market:
CloudflareIBM CloudOracleSalesforceGoogleServiceNowApache StratosWindows AzureAWSOpenShiftPleskZoho CreatorRed HatVMwareSAP
Browse the complete report @ https://www.orbisresearch.com/reports/index/global-cloud-computing-platform-as-a-service-paas-market-report-2020
The Global Cloud Computing Platform as a Service (PaaS) Market report majorly focuses on the viability of advanced investment projects. Also, the Global Cloud Computing Platform as a Service (PaaS) Market report presented broad analysis for the global markets such as competitive landscape exploration, development trends, and crucial regions expansion status. Additionally, development policies & plans are evaluated as well as cost structures and business processes are also extensively discussed in the Global Cloud Computing Platform as a Service (PaaS) Market report. Global Info Research study also delivers supply & demand, import and export consumption, price, cost, revenue, and gross margins.
Global Market By Type:
Video Communication PaasCloud Telephony PaasWeb and Mobile Optimization
Global Market By Application:
The Global Cloud Computing Platform as a Service (PaaS) Market research study is intended with tables & figures that helps to get a better image of the target market. Also, the report delivers key indicators of the Global Cloud Computing Platform as a Service (PaaS) Market and it is a major source of direction and regulation for individuals and businesses interested in the market. This report embraces in-depth data about current and upcoming market trends.
Make an enquire of this report @ https://www.orbisresearch.com/contacts/enquiry-before-buying/4629251
About Us :
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Contact Us :
Hector CostelloSenior Manager Client Engagements4144N Central Expressway,Suite 600, Dallas,Texas 75204, U.S.A.Phone No.: USA: +1 (972)-362-8199 | IND: +91 895 659 5155
Read more from the original source: